Successful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population

Table 3

Therapeutic drug monitoring results of posaconazole.

Posaconazole, quantitative by LC-MS/MS
Patient 1	HD27; HD29; HD41; HD53; HD62; HD64; HD71; HD75	0.4 μg/mL; 0.7 μg/mL; 1.1 μg/mL; 0.6 μg/mL; 0.7 μg/mL; 0.4 μg/mL; 1.2 μg/mL; 1.3 μg/mL
Patient 2	POD38; POD62; POD76	0.6 μg/mL; 0.6 μg/mL; 1.7 μg/mL
Patient 3	POD21; POD27; POD53; POD54; POD126	0.8 μg/mL; 0.7 μg/mL; 2.7 μg/mL; 1.7 μg/mL; 0.9 μg/mL

HD: hospital day; POD: postoperation day.